Abstract
Background: Evaluation of angiogenesis-inducing compounds is essential in tissue engineering to develop biological substitutes for the repair or regeneration of tissue function. In this report, we evaluated the angiogenic ability of ginsenoside Rg 1 from Panax ginseng, in Matrigel implanted on fluorescent transgenic mice. Methods: The in vitro proliferation ability of each test agent was estimated by MTS assay. The Matrigel loaded with basic fibroblast growth factor (bFGF) or Rg 1 and Matrigel alone were implanted on fluorescent transgenic mice and were retrieved at 1, 4, 6 and 8 weeks after implantation to measure various conventional markers for angiogenesis including neo-vascular density and hemoglobin content. Additionally, the functional neo-vasculature in the implanted Matrigel was visualized using confocal laser scanning microscopy (CLSM). Results: The in vitro results indicated that the stimulating effect of Rg 1 on HUVECs proliferation remained unchanged after dissolved for 30 days in culture medium at 37 °C when compared with the effect of bFGF. One week after implantation in transgenic mice, bFGF or Rg 1 mixed in Matrigel plug significantly enhanced angiogenesis; however, at 6 weeks a significant decrease in angiogenic effect was observed in Matrigel with bFGF, but not in Matrigel with Rg 1 . The neo-vessels structure was visualized in three dimensions (3D) by CLSM and the results were in agreement with other conventional measurements for angiogenesis. Conclusion: These findings confirm that Rg 1 could be used in tissue tissue-engineering applications and that the fluorescent transgenic mice can be a useful experimental model for studying angiogenesis. © 2008 Elsevier Inc. All rights reserved.